Policy Development Working Group
EMA COLLABORATION Task Force
Mission: Closely collaborate with the European Medicine Agency (EMA) to inform them about the progress of in silico methods and learn about EMA requirements to accept digital evidence
Chair: Liesbet Geris (VPHi)
- Publish a white paper about the use of in silico methods to provide digital evidences for pharmaceutical applications.
- Informal small-scale closed meetings every 2 months to have fast communication on most interesting topics to work on.
- Public Triple Helix expertise exchange workshops between EMA, industry & academia: first edition on drug-device interaction in Q2, follow up in Q3.